Pharma & Healthcare
Global Human Insulin Injections Market Research Report 2026
- Mar 17, 26
- ID: 738070
- Pages: 108
- Figures: 115
- Views: 6
This report delivers a comprehensive overview of the global Human Insulin Injections market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Human Insulin Injections. The Human Insulin Injections market size, estimates, and forecasts are provided in terms of sales volume (K Dose) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Human Insulin Injections market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Human Insulin Injections manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
BIOTON S.A.
Lilly France
Novo Nordisk
Eli Lilly
Sanofi-Aventis
Tonghua Dongbao
Ganlee
United Laboratory
Jiangsu Wanbang
Segment by Type
3ml
10ml
by Application
Hospital
Clinic
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Human Insulin Injections manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Human Insulin Injections sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
The report segments the global Human Insulin Injections market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Human Insulin Injections manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
BIOTON S.A.
Lilly France
Novo Nordisk
Eli Lilly
Sanofi-Aventis
Tonghua Dongbao
Ganlee
United Laboratory
Jiangsu Wanbang
Segment by Type
3ml
10ml
by Application
Hospital
Clinic
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Human Insulin Injections manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Human Insulin Injections sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
1 Human Insulin Injections Market Overview
1.1 Product Definition
1.2 Human Insulin Injections by Type
1.2.1 Global Human Insulin Injections Market Value by Type: 2025 vs 2032
1.2.2 3ml
1.2.3 10ml
1.3 Human Insulin Injections by Application
1.3.1 Global Human Insulin Injections Market Value by Application: 2025 vs 2032
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Human Insulin Injections Market Size Estimates and Forecasts
1.4.1 Global Human Insulin Injections Revenue 2021–2032
1.4.2 Global Human Insulin Injections Sales 2021–2032
1.4.3 Global Human Insulin Injections Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Human Insulin Injections Market Competition by Manufacturers
2.1 Global Human Insulin Injections Sales Market Share by Manufacturers (2021–2026)
2.2 Global Human Insulin Injections Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Human Insulin Injections Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Human Insulin Injections, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Human Insulin Injections, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Human Insulin Injections, Product Types and Applications
2.7 Global Key Manufacturers of Human Insulin Injections, Date of Entry into the Industry
2.8 Global Human Insulin Injections Market Competitive Situation and Trends
2.8.1 Global Human Insulin Injections Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Human Insulin Injections Players Market Share by Revenue
2.8.3 Global Human Insulin Injections Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Human Insulin Injections Market Scenario by Region
3.1 Global Human Insulin Injections Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Human Insulin Injections Sales by Region: 2021–2032
3.2.1 Global Human Insulin Injections Sales by Region: 2021–2026
3.2.2 Global Human Insulin Injections Sales by Region: 2027–2032
3.3 Global Human Insulin Injections Revenue by Region: 2021–2032
3.3.1 Global Human Insulin Injections Revenue by Region: 2021–2026
3.3.2 Global Human Insulin Injections Revenue by Region: 2027–2032
3.4 North America Human Insulin Injections Market Facts & Figures by Country
3.4.1 North America Human Insulin Injections Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Human Insulin Injections Sales by Country (2021–2032)
3.4.3 North America Human Insulin Injections Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Human Insulin Injections Market Facts & Figures by Country
3.5.1 Europe Human Insulin Injections Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Human Insulin Injections Sales by Country (2021–2032)
3.5.3 Europe Human Insulin Injections Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Human Insulin Injections Market Facts & Figures by Region
3.6.1 Asia Pacific Human Insulin Injections Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Human Insulin Injections Sales by Region (2021–2032)
3.6.3 Asia Pacific Human Insulin Injections Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Human Insulin Injections Market Facts & Figures by Country
3.7.1 Latin America Human Insulin Injections Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Human Insulin Injections Sales by Country (2021–2032)
3.7.3 Latin America Human Insulin Injections Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Human Insulin Injections Market Facts & Figures by Country
3.8.1 Middle East and Africa Human Insulin Injections Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Human Insulin Injections Sales by Country (2021–2032)
3.8.3 Middle East and Africa Human Insulin Injections Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Human Insulin Injections Sales by Type (2021–2032)
4.1.1 Global Human Insulin Injections Sales by Type (2021–2026)
4.1.2 Global Human Insulin Injections Sales by Type (2027–2032)
4.1.3 Global Human Insulin Injections Sales Market Share by Type (2021–2032)
4.2 Global Human Insulin Injections Revenue by Type (2021–2032)
4.2.1 Global Human Insulin Injections Revenue by Type (2021–2026)
4.2.2 Global Human Insulin Injections Revenue by Type (2027–2032)
4.2.3 Global Human Insulin Injections Revenue Market Share by Type (2021–2032)
4.3 Global Human Insulin Injections Price by Type (2021–2032)
5 Segment by Application
5.1 Global Human Insulin Injections Sales by Application (2021–2032)
5.1.1 Global Human Insulin Injections Sales by Application (2021–2026)
5.1.2 Global Human Insulin Injections Sales by Application (2027–2032)
5.1.3 Global Human Insulin Injections Sales Market Share by Application (2021–2032)
5.2 Global Human Insulin Injections Revenue by Application (2021–2032)
5.2.1 Global Human Insulin Injections Revenue by Application (2021–2026)
5.2.2 Global Human Insulin Injections Revenue by Application (2027–2032)
5.2.3 Global Human Insulin Injections Revenue Market Share by Application (2021–2032)
5.3 Global Human Insulin Injections Price by Application (2021–2032)
6 Key Companies Profiled
6.1 BIOTON S.A.
6.1.1 BIOTON S.A. Company Information
6.1.2 BIOTON S.A. Description and Business Overview
6.1.3 BIOTON S.A. Human Insulin Injections Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 BIOTON S.A. Human Insulin Injections Product Portfolio
6.1.5 BIOTON S.A. Recent Developments/Updates
6.2 Lilly France
6.2.1 Lilly France Company Information
6.2.2 Lilly France Description and Business Overview
6.2.3 Lilly France Human Insulin Injections Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Lilly France Human Insulin Injections Product Portfolio
6.2.5 Lilly France Recent Developments/Updates
6.3 Novo Nordisk
6.3.1 Novo Nordisk Company Information
6.3.2 Novo Nordisk Description and Business Overview
6.3.3 Novo Nordisk Human Insulin Injections Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Novo Nordisk Human Insulin Injections Product Portfolio
6.3.5 Novo Nordisk Recent Developments/Updates
6.4 Eli Lilly
6.4.1 Eli Lilly Company Information
6.4.2 Eli Lilly Description and Business Overview
6.4.3 Eli Lilly Human Insulin Injections Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Eli Lilly Human Insulin Injections Product Portfolio
6.4.5 Eli Lilly Recent Developments/Updates
6.5 Sanofi-Aventis
6.5.1 Sanofi-Aventis Company Information
6.5.2 Sanofi-Aventis Description and Business Overview
6.5.3 Sanofi-Aventis Human Insulin Injections Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Sanofi-Aventis Human Insulin Injections Product Portfolio
6.5.5 Sanofi-Aventis Recent Developments/Updates
6.6 Tonghua Dongbao
6.6.1 Tonghua Dongbao Company Information
6.6.2 Tonghua Dongbao Description and Business Overview
6.6.3 Tonghua Dongbao Human Insulin Injections Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Tonghua Dongbao Human Insulin Injections Product Portfolio
6.6.5 Tonghua Dongbao Recent Developments/Updates
6.7 Ganlee
6.7.1 Ganlee Company Information
6.7.2 Ganlee Description and Business Overview
6.7.3 Ganlee Human Insulin Injections Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Ganlee Human Insulin Injections Product Portfolio
6.7.5 Ganlee Recent Developments/Updates
6.8 United Laboratory
6.8.1 United Laboratory Company Information
6.8.2 United Laboratory Description and Business Overview
6.8.3 United Laboratory Human Insulin Injections Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 United Laboratory Human Insulin Injections Product Portfolio
6.8.5 United Laboratory Recent Developments/Updates
6.9 Jiangsu Wanbang
6.9.1 Jiangsu Wanbang Company Information
6.9.2 Jiangsu Wanbang Description and Business Overview
6.9.3 Jiangsu Wanbang Human Insulin Injections Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Jiangsu Wanbang Human Insulin Injections Product Portfolio
6.9.5 Jiangsu Wanbang Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Human Insulin Injections Industry Chain Analysis
7.2 Human Insulin Injections Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Human Insulin Injections Production Mode & Process Analysis
7.4 Human Insulin Injections Sales and Marketing
7.4.1 Human Insulin Injections Sales Channels
7.4.2 Human Insulin Injections Distributors
7.5 Human Insulin Injections Customer Analysis
8 Human Insulin Injections Market Dynamics
8.1 Human Insulin Injections Industry Trends
8.2 Human Insulin Injections Market Drivers
8.3 Human Insulin Injections Market Challenges
8.4 Human Insulin Injections Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Human Insulin Injections by Type
1.2.1 Global Human Insulin Injections Market Value by Type: 2025 vs 2032
1.2.2 3ml
1.2.3 10ml
1.3 Human Insulin Injections by Application
1.3.1 Global Human Insulin Injections Market Value by Application: 2025 vs 2032
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Human Insulin Injections Market Size Estimates and Forecasts
1.4.1 Global Human Insulin Injections Revenue 2021–2032
1.4.2 Global Human Insulin Injections Sales 2021–2032
1.4.3 Global Human Insulin Injections Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Human Insulin Injections Market Competition by Manufacturers
2.1 Global Human Insulin Injections Sales Market Share by Manufacturers (2021–2026)
2.2 Global Human Insulin Injections Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Human Insulin Injections Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Human Insulin Injections, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Human Insulin Injections, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Human Insulin Injections, Product Types and Applications
2.7 Global Key Manufacturers of Human Insulin Injections, Date of Entry into the Industry
2.8 Global Human Insulin Injections Market Competitive Situation and Trends
2.8.1 Global Human Insulin Injections Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Human Insulin Injections Players Market Share by Revenue
2.8.3 Global Human Insulin Injections Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Human Insulin Injections Market Scenario by Region
3.1 Global Human Insulin Injections Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Human Insulin Injections Sales by Region: 2021–2032
3.2.1 Global Human Insulin Injections Sales by Region: 2021–2026
3.2.2 Global Human Insulin Injections Sales by Region: 2027–2032
3.3 Global Human Insulin Injections Revenue by Region: 2021–2032
3.3.1 Global Human Insulin Injections Revenue by Region: 2021–2026
3.3.2 Global Human Insulin Injections Revenue by Region: 2027–2032
3.4 North America Human Insulin Injections Market Facts & Figures by Country
3.4.1 North America Human Insulin Injections Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Human Insulin Injections Sales by Country (2021–2032)
3.4.3 North America Human Insulin Injections Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Human Insulin Injections Market Facts & Figures by Country
3.5.1 Europe Human Insulin Injections Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Human Insulin Injections Sales by Country (2021–2032)
3.5.3 Europe Human Insulin Injections Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Human Insulin Injections Market Facts & Figures by Region
3.6.1 Asia Pacific Human Insulin Injections Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Human Insulin Injections Sales by Region (2021–2032)
3.6.3 Asia Pacific Human Insulin Injections Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Human Insulin Injections Market Facts & Figures by Country
3.7.1 Latin America Human Insulin Injections Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Human Insulin Injections Sales by Country (2021–2032)
3.7.3 Latin America Human Insulin Injections Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Human Insulin Injections Market Facts & Figures by Country
3.8.1 Middle East and Africa Human Insulin Injections Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Human Insulin Injections Sales by Country (2021–2032)
3.8.3 Middle East and Africa Human Insulin Injections Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Human Insulin Injections Sales by Type (2021–2032)
4.1.1 Global Human Insulin Injections Sales by Type (2021–2026)
4.1.2 Global Human Insulin Injections Sales by Type (2027–2032)
4.1.3 Global Human Insulin Injections Sales Market Share by Type (2021–2032)
4.2 Global Human Insulin Injections Revenue by Type (2021–2032)
4.2.1 Global Human Insulin Injections Revenue by Type (2021–2026)
4.2.2 Global Human Insulin Injections Revenue by Type (2027–2032)
4.2.3 Global Human Insulin Injections Revenue Market Share by Type (2021–2032)
4.3 Global Human Insulin Injections Price by Type (2021–2032)
5 Segment by Application
5.1 Global Human Insulin Injections Sales by Application (2021–2032)
5.1.1 Global Human Insulin Injections Sales by Application (2021–2026)
5.1.2 Global Human Insulin Injections Sales by Application (2027–2032)
5.1.3 Global Human Insulin Injections Sales Market Share by Application (2021–2032)
5.2 Global Human Insulin Injections Revenue by Application (2021–2032)
5.2.1 Global Human Insulin Injections Revenue by Application (2021–2026)
5.2.2 Global Human Insulin Injections Revenue by Application (2027–2032)
5.2.3 Global Human Insulin Injections Revenue Market Share by Application (2021–2032)
5.3 Global Human Insulin Injections Price by Application (2021–2032)
6 Key Companies Profiled
6.1 BIOTON S.A.
6.1.1 BIOTON S.A. Company Information
6.1.2 BIOTON S.A. Description and Business Overview
6.1.3 BIOTON S.A. Human Insulin Injections Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 BIOTON S.A. Human Insulin Injections Product Portfolio
6.1.5 BIOTON S.A. Recent Developments/Updates
6.2 Lilly France
6.2.1 Lilly France Company Information
6.2.2 Lilly France Description and Business Overview
6.2.3 Lilly France Human Insulin Injections Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Lilly France Human Insulin Injections Product Portfolio
6.2.5 Lilly France Recent Developments/Updates
6.3 Novo Nordisk
6.3.1 Novo Nordisk Company Information
6.3.2 Novo Nordisk Description and Business Overview
6.3.3 Novo Nordisk Human Insulin Injections Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Novo Nordisk Human Insulin Injections Product Portfolio
6.3.5 Novo Nordisk Recent Developments/Updates
6.4 Eli Lilly
6.4.1 Eli Lilly Company Information
6.4.2 Eli Lilly Description and Business Overview
6.4.3 Eli Lilly Human Insulin Injections Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Eli Lilly Human Insulin Injections Product Portfolio
6.4.5 Eli Lilly Recent Developments/Updates
6.5 Sanofi-Aventis
6.5.1 Sanofi-Aventis Company Information
6.5.2 Sanofi-Aventis Description and Business Overview
6.5.3 Sanofi-Aventis Human Insulin Injections Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Sanofi-Aventis Human Insulin Injections Product Portfolio
6.5.5 Sanofi-Aventis Recent Developments/Updates
6.6 Tonghua Dongbao
6.6.1 Tonghua Dongbao Company Information
6.6.2 Tonghua Dongbao Description and Business Overview
6.6.3 Tonghua Dongbao Human Insulin Injections Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Tonghua Dongbao Human Insulin Injections Product Portfolio
6.6.5 Tonghua Dongbao Recent Developments/Updates
6.7 Ganlee
6.7.1 Ganlee Company Information
6.7.2 Ganlee Description and Business Overview
6.7.3 Ganlee Human Insulin Injections Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Ganlee Human Insulin Injections Product Portfolio
6.7.5 Ganlee Recent Developments/Updates
6.8 United Laboratory
6.8.1 United Laboratory Company Information
6.8.2 United Laboratory Description and Business Overview
6.8.3 United Laboratory Human Insulin Injections Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 United Laboratory Human Insulin Injections Product Portfolio
6.8.5 United Laboratory Recent Developments/Updates
6.9 Jiangsu Wanbang
6.9.1 Jiangsu Wanbang Company Information
6.9.2 Jiangsu Wanbang Description and Business Overview
6.9.3 Jiangsu Wanbang Human Insulin Injections Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Jiangsu Wanbang Human Insulin Injections Product Portfolio
6.9.5 Jiangsu Wanbang Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Human Insulin Injections Industry Chain Analysis
7.2 Human Insulin Injections Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Human Insulin Injections Production Mode & Process Analysis
7.4 Human Insulin Injections Sales and Marketing
7.4.1 Human Insulin Injections Sales Channels
7.4.2 Human Insulin Injections Distributors
7.5 Human Insulin Injections Customer Analysis
8 Human Insulin Injections Market Dynamics
8.1 Human Insulin Injections Industry Trends
8.2 Human Insulin Injections Market Drivers
8.3 Human Insulin Injections Market Challenges
8.4 Human Insulin Injections Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Human Insulin Injections Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Human Insulin Injections Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Human Insulin Injections Market Competitive Situation by Manufacturers in 2025
Table 4. Global Human Insulin Injections Sales (K Dose) of Key Manufacturers (2021–2026)
Table 5. Global Human Insulin Injections Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Human Insulin Injections Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Human Insulin Injections Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Human Insulin Injections Average Price (US$/Dose) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Human Insulin Injections, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Human Insulin Injections, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Human Insulin Injections, Product Types and Applications
Table 12. Global Key Manufacturers of Human Insulin Injections, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Human Insulin Injections Companies by Tier (Tier 1, Tier 2, Tier 3), based on Human Insulin Injections Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Human Insulin Injections Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Human Insulin Injections Sales by Region (K Dose), 2021–2026
Table 18. Global Human Insulin Injections Sales Market Share by Region (2021–2026)
Table 19. Global Human Insulin Injections Sales by Region (K Dose), 2027–2032
Table 20. Global Human Insulin Injections Sales Market Share by Region (2027–2032)
Table 21. Global Human Insulin Injections Revenue by Region (US$ Million), 2021–2026
Table 22. Global Human Insulin Injections Revenue Market Share by Region (2021–2026)
Table 23. Global Human Insulin Injections Revenue by Region (US$ Million), 2027–2032
Table 24. Global Human Insulin Injections Revenue Market Share by Region (2027–2032)
Table 25. North America Human Insulin Injections Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Human Insulin Injections Sales by Country (K Dose), 2021–2026
Table 27. North America Human Insulin Injections Sales by Country (K Dose), 2027–2032
Table 28. North America Human Insulin Injections Revenue by Country (US$ Million), 2021–2026
Table 29. North America Human Insulin Injections Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Human Insulin Injections Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Human Insulin Injections Sales by Country (K Dose), 2021–2026
Table 32. Europe Human Insulin Injections Sales by Country (K Dose), 2027–2032
Table 33. Europe Human Insulin Injections Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Human Insulin Injections Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Human Insulin Injections Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Human Insulin Injections Sales by Region (K Dose), 2021–2026
Table 37. Asia Pacific Human Insulin Injections Sales by Region (K Dose), 2027–2032
Table 38. Asia Pacific Human Insulin Injections Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Human Insulin Injections Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Human Insulin Injections Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Human Insulin Injections Sales by Country (K Dose), 2021–2026
Table 42. Latin America Human Insulin Injections Sales by Country (K Dose), 2027–2032
Table 43. Latin America Human Insulin Injections Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Human Insulin Injections Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Human Insulin Injections Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Human Insulin Injections Sales by Country (K Dose), 2021–2026
Table 47. Middle East and Africa Human Insulin Injections Sales by Country (K Dose), 2027–2032
Table 48. Middle East and Africa Human Insulin Injections Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Human Insulin Injections Revenue by Country (US$ Million), 2027–2032
Table 50. Global Human Insulin Injections Sales (K Dose) by Type (2021–2026)
Table 51. Global Human Insulin Injections Sales (K Dose) by Type (2027–2032)
Table 52. Global Human Insulin Injections Sales Market Share by Type (2021–2026)
Table 53. Global Human Insulin Injections Sales Market Share by Type (2027–2032)
Table 54. Global Human Insulin Injections Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Human Insulin Injections Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Human Insulin Injections Revenue Market Share by Type (2021–2026)
Table 57. Global Human Insulin Injections Revenue Market Share by Type (2027–2032)
Table 58. Global Human Insulin Injections Price (US$/Dose) by Type (2021–2026)
Table 59. Global Human Insulin Injections Price (US$/Dose) by Type (2027–2032)
Table 60. Global Human Insulin Injections Sales (K Dose) by Application (2021–2026)
Table 61. Global Human Insulin Injections Sales (K Dose) by Application (2027–2032)
Table 62. Global Human Insulin Injections Sales Market Share by Application (2021–2026)
Table 63. Global Human Insulin Injections Sales Market Share by Application (2027–2032)
Table 64. Global Human Insulin Injections Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Human Insulin Injections Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Human Insulin Injections Revenue Market Share by Application (2021–2026)
Table 67. Global Human Insulin Injections Revenue Market Share by Application (2027–2032)
Table 68. Global Human Insulin Injections Price (US$/Dose) by Application (2021–2026)
Table 69. Global Human Insulin Injections Price (US$/Dose) by Application (2027–2032)
Table 70. BIOTON S.A. Company Information
Table 71. BIOTON S.A. Description and Business Overview
Table 72. BIOTON S.A. Human Insulin Injections Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 73. BIOTON S.A. Human Insulin Injections Product
Table 74. BIOTON S.A. Recent Developments/Updates
Table 75. Lilly France Company Information
Table 76. Lilly France Description and Business Overview
Table 77. Lilly France Human Insulin Injections Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 78. Lilly France Human Insulin Injections Product
Table 79. Lilly France Recent Developments/Updates
Table 80. Novo Nordisk Company Information
Table 81. Novo Nordisk Description and Business Overview
Table 82. Novo Nordisk Human Insulin Injections Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 83. Novo Nordisk Human Insulin Injections Product
Table 84. Novo Nordisk Recent Developments/Updates
Table 85. Eli Lilly Company Information
Table 86. Eli Lilly Description and Business Overview
Table 87. Eli Lilly Human Insulin Injections Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 88. Eli Lilly Human Insulin Injections Product
Table 89. Eli Lilly Recent Developments/Updates
Table 90. Sanofi-Aventis Company Information
Table 91. Sanofi-Aventis Description and Business Overview
Table 92. Sanofi-Aventis Human Insulin Injections Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 93. Sanofi-Aventis Human Insulin Injections Product
Table 94. Sanofi-Aventis Recent Developments/Updates
Table 95. Tonghua Dongbao Company Information
Table 96. Tonghua Dongbao Description and Business Overview
Table 97. Tonghua Dongbao Human Insulin Injections Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 98. Tonghua Dongbao Human Insulin Injections Product
Table 99. Tonghua Dongbao Recent Developments/Updates
Table 100. Ganlee Company Information
Table 101. Ganlee Description and Business Overview
Table 102. Ganlee Human Insulin Injections Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 103. Ganlee Human Insulin Injections Product
Table 104. Ganlee Recent Developments/Updates
Table 105. United Laboratory Company Information
Table 106. United Laboratory Description and Business Overview
Table 107. United Laboratory Human Insulin Injections Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 108. United Laboratory Human Insulin Injections Product
Table 109. United Laboratory Recent Developments/Updates
Table 110. Jiangsu Wanbang Company Information
Table 111. Jiangsu Wanbang Description and Business Overview
Table 112. Jiangsu Wanbang Human Insulin Injections Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 113. Jiangsu Wanbang Human Insulin Injections Product
Table 114. Jiangsu Wanbang Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Human Insulin Injections Distributors List
Table 118. Human Insulin Injections Customers List
Table 119. Human Insulin Injections Market Trends
Table 120. Human Insulin Injections Market Drivers
Table 121. Human Insulin Injections Market Challenges
Table 122. Human Insulin Injections Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 126. Authors List of This Report
List of Figures
Figure 1. Product Picture of Human Insulin Injections
Figure 2. Global Human Insulin Injections Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Human Insulin Injections Market Share by Type: 2025 & 2032
Figure 4. 3ml Product Picture
Figure 5. 10ml Product Picture
Figure 6. Global Human Insulin Injections Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Human Insulin Injections Market Share by Application: 2025 & 2032
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Others
Figure 11. Global Human Insulin Injections Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global Human Insulin Injections Market Size (US$ Million), 2021–2032
Figure 13. Global Human Insulin Injections Sales (K Dose), 2021–2032
Figure 14. Global Human Insulin Injections Average Price (US$/Dose), 2021–2032
Figure 15. Human Insulin Injections Report Years Considered
Figure 16. Human Insulin Injections Sales Share by Manufacturers in 2025
Figure 17. Global Human Insulin Injections Revenue Share by Manufacturers in 2025
Figure 18. Top 5 and Top 10 Global Human Insulin Injections Players: Market Share by Revenue in Human Insulin Injections in 2025
Figure 19. Human Insulin Injections Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 20. Global Human Insulin Injections Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 21. North America Human Insulin Injections Sales Market Share by Country (2021–2032)
Figure 22. North America Human Insulin Injections Revenue Market Share by Country (2021–2032)
Figure 23. United States Human Insulin Injections Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Canada Human Insulin Injections Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Europe Human Insulin Injections Sales Market Share by Country (2021–2032)
Figure 26. Europe Human Insulin Injections Revenue Market Share by Country (2021–2032)
Figure 27. Germany Human Insulin Injections Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. France Human Insulin Injections Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. U.K. Human Insulin Injections Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Italy Human Insulin Injections Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Russia Human Insulin Injections Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Asia Pacific Human Insulin Injections Sales Market Share by Region (2021–2032)
Figure 33. Asia Pacific Human Insulin Injections Revenue Market Share by Region (2021–2032)
Figure 34. China Human Insulin Injections Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Japan Human Insulin Injections Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. South Korea Human Insulin Injections Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. India Human Insulin Injections Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Australia Human Insulin Injections Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. China Taiwan Human Insulin Injections Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Southeast Asia Human Insulin Injections Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Latin America Human Insulin Injections Sales Market Share by Country (2021–2032)
Figure 42. Latin America Human Insulin Injections Revenue Market Share by Country (2021–2032)
Figure 43. Mexico Human Insulin Injections Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Brazil Human Insulin Injections Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Argentina Human Insulin Injections Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Colombia Human Insulin Injections Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Middle East and Africa Human Insulin Injections Sales Market Share by Country (2021–2032)
Figure 48. Middle East and Africa Human Insulin Injections Revenue Market Share by Country (2021–2032)
Figure 49. Turkey Human Insulin Injections Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Saudi Arabia Human Insulin Injections Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. UAE Human Insulin Injections Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Global Sales Market Share of Human Insulin Injections by Type (2021–2032)
Figure 53. Global Revenue Market Share of Human Insulin Injections by Type (2021–2032)
Figure 54. Global Human Insulin Injections Price (US$/Dose) by Type (2021–2032)
Figure 55. Global Sales Market Share of Human Insulin Injections by Application (2021–2032)
Figure 56. Global Revenue Market Share of Human Insulin Injections by Application (2021–2032)
Figure 57. Global Human Insulin Injections Price (US$/Dose) by Application (2021–2032)
Figure 58. Human Insulin Injections Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Table 1. Global Human Insulin Injections Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Human Insulin Injections Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Human Insulin Injections Market Competitive Situation by Manufacturers in 2025
Table 4. Global Human Insulin Injections Sales (K Dose) of Key Manufacturers (2021–2026)
Table 5. Global Human Insulin Injections Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Human Insulin Injections Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Human Insulin Injections Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Human Insulin Injections Average Price (US$/Dose) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Human Insulin Injections, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Human Insulin Injections, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Human Insulin Injections, Product Types and Applications
Table 12. Global Key Manufacturers of Human Insulin Injections, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Human Insulin Injections Companies by Tier (Tier 1, Tier 2, Tier 3), based on Human Insulin Injections Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Human Insulin Injections Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Human Insulin Injections Sales by Region (K Dose), 2021–2026
Table 18. Global Human Insulin Injections Sales Market Share by Region (2021–2026)
Table 19. Global Human Insulin Injections Sales by Region (K Dose), 2027–2032
Table 20. Global Human Insulin Injections Sales Market Share by Region (2027–2032)
Table 21. Global Human Insulin Injections Revenue by Region (US$ Million), 2021–2026
Table 22. Global Human Insulin Injections Revenue Market Share by Region (2021–2026)
Table 23. Global Human Insulin Injections Revenue by Region (US$ Million), 2027–2032
Table 24. Global Human Insulin Injections Revenue Market Share by Region (2027–2032)
Table 25. North America Human Insulin Injections Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Human Insulin Injections Sales by Country (K Dose), 2021–2026
Table 27. North America Human Insulin Injections Sales by Country (K Dose), 2027–2032
Table 28. North America Human Insulin Injections Revenue by Country (US$ Million), 2021–2026
Table 29. North America Human Insulin Injections Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Human Insulin Injections Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Human Insulin Injections Sales by Country (K Dose), 2021–2026
Table 32. Europe Human Insulin Injections Sales by Country (K Dose), 2027–2032
Table 33. Europe Human Insulin Injections Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Human Insulin Injections Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Human Insulin Injections Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Human Insulin Injections Sales by Region (K Dose), 2021–2026
Table 37. Asia Pacific Human Insulin Injections Sales by Region (K Dose), 2027–2032
Table 38. Asia Pacific Human Insulin Injections Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Human Insulin Injections Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Human Insulin Injections Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Human Insulin Injections Sales by Country (K Dose), 2021–2026
Table 42. Latin America Human Insulin Injections Sales by Country (K Dose), 2027–2032
Table 43. Latin America Human Insulin Injections Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Human Insulin Injections Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Human Insulin Injections Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Human Insulin Injections Sales by Country (K Dose), 2021–2026
Table 47. Middle East and Africa Human Insulin Injections Sales by Country (K Dose), 2027–2032
Table 48. Middle East and Africa Human Insulin Injections Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Human Insulin Injections Revenue by Country (US$ Million), 2027–2032
Table 50. Global Human Insulin Injections Sales (K Dose) by Type (2021–2026)
Table 51. Global Human Insulin Injections Sales (K Dose) by Type (2027–2032)
Table 52. Global Human Insulin Injections Sales Market Share by Type (2021–2026)
Table 53. Global Human Insulin Injections Sales Market Share by Type (2027–2032)
Table 54. Global Human Insulin Injections Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Human Insulin Injections Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Human Insulin Injections Revenue Market Share by Type (2021–2026)
Table 57. Global Human Insulin Injections Revenue Market Share by Type (2027–2032)
Table 58. Global Human Insulin Injections Price (US$/Dose) by Type (2021–2026)
Table 59. Global Human Insulin Injections Price (US$/Dose) by Type (2027–2032)
Table 60. Global Human Insulin Injections Sales (K Dose) by Application (2021–2026)
Table 61. Global Human Insulin Injections Sales (K Dose) by Application (2027–2032)
Table 62. Global Human Insulin Injections Sales Market Share by Application (2021–2026)
Table 63. Global Human Insulin Injections Sales Market Share by Application (2027–2032)
Table 64. Global Human Insulin Injections Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Human Insulin Injections Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Human Insulin Injections Revenue Market Share by Application (2021–2026)
Table 67. Global Human Insulin Injections Revenue Market Share by Application (2027–2032)
Table 68. Global Human Insulin Injections Price (US$/Dose) by Application (2021–2026)
Table 69. Global Human Insulin Injections Price (US$/Dose) by Application (2027–2032)
Table 70. BIOTON S.A. Company Information
Table 71. BIOTON S.A. Description and Business Overview
Table 72. BIOTON S.A. Human Insulin Injections Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 73. BIOTON S.A. Human Insulin Injections Product
Table 74. BIOTON S.A. Recent Developments/Updates
Table 75. Lilly France Company Information
Table 76. Lilly France Description and Business Overview
Table 77. Lilly France Human Insulin Injections Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 78. Lilly France Human Insulin Injections Product
Table 79. Lilly France Recent Developments/Updates
Table 80. Novo Nordisk Company Information
Table 81. Novo Nordisk Description and Business Overview
Table 82. Novo Nordisk Human Insulin Injections Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 83. Novo Nordisk Human Insulin Injections Product
Table 84. Novo Nordisk Recent Developments/Updates
Table 85. Eli Lilly Company Information
Table 86. Eli Lilly Description and Business Overview
Table 87. Eli Lilly Human Insulin Injections Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 88. Eli Lilly Human Insulin Injections Product
Table 89. Eli Lilly Recent Developments/Updates
Table 90. Sanofi-Aventis Company Information
Table 91. Sanofi-Aventis Description and Business Overview
Table 92. Sanofi-Aventis Human Insulin Injections Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 93. Sanofi-Aventis Human Insulin Injections Product
Table 94. Sanofi-Aventis Recent Developments/Updates
Table 95. Tonghua Dongbao Company Information
Table 96. Tonghua Dongbao Description and Business Overview
Table 97. Tonghua Dongbao Human Insulin Injections Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 98. Tonghua Dongbao Human Insulin Injections Product
Table 99. Tonghua Dongbao Recent Developments/Updates
Table 100. Ganlee Company Information
Table 101. Ganlee Description and Business Overview
Table 102. Ganlee Human Insulin Injections Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 103. Ganlee Human Insulin Injections Product
Table 104. Ganlee Recent Developments/Updates
Table 105. United Laboratory Company Information
Table 106. United Laboratory Description and Business Overview
Table 107. United Laboratory Human Insulin Injections Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 108. United Laboratory Human Insulin Injections Product
Table 109. United Laboratory Recent Developments/Updates
Table 110. Jiangsu Wanbang Company Information
Table 111. Jiangsu Wanbang Description and Business Overview
Table 112. Jiangsu Wanbang Human Insulin Injections Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 113. Jiangsu Wanbang Human Insulin Injections Product
Table 114. Jiangsu Wanbang Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Human Insulin Injections Distributors List
Table 118. Human Insulin Injections Customers List
Table 119. Human Insulin Injections Market Trends
Table 120. Human Insulin Injections Market Drivers
Table 121. Human Insulin Injections Market Challenges
Table 122. Human Insulin Injections Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 126. Authors List of This Report
List of Figures
Figure 1. Product Picture of Human Insulin Injections
Figure 2. Global Human Insulin Injections Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Human Insulin Injections Market Share by Type: 2025 & 2032
Figure 4. 3ml Product Picture
Figure 5. 10ml Product Picture
Figure 6. Global Human Insulin Injections Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Human Insulin Injections Market Share by Application: 2025 & 2032
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Others
Figure 11. Global Human Insulin Injections Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global Human Insulin Injections Market Size (US$ Million), 2021–2032
Figure 13. Global Human Insulin Injections Sales (K Dose), 2021–2032
Figure 14. Global Human Insulin Injections Average Price (US$/Dose), 2021–2032
Figure 15. Human Insulin Injections Report Years Considered
Figure 16. Human Insulin Injections Sales Share by Manufacturers in 2025
Figure 17. Global Human Insulin Injections Revenue Share by Manufacturers in 2025
Figure 18. Top 5 and Top 10 Global Human Insulin Injections Players: Market Share by Revenue in Human Insulin Injections in 2025
Figure 19. Human Insulin Injections Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 20. Global Human Insulin Injections Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 21. North America Human Insulin Injections Sales Market Share by Country (2021–2032)
Figure 22. North America Human Insulin Injections Revenue Market Share by Country (2021–2032)
Figure 23. United States Human Insulin Injections Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Canada Human Insulin Injections Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Europe Human Insulin Injections Sales Market Share by Country (2021–2032)
Figure 26. Europe Human Insulin Injections Revenue Market Share by Country (2021–2032)
Figure 27. Germany Human Insulin Injections Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. France Human Insulin Injections Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. U.K. Human Insulin Injections Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Italy Human Insulin Injections Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Russia Human Insulin Injections Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Asia Pacific Human Insulin Injections Sales Market Share by Region (2021–2032)
Figure 33. Asia Pacific Human Insulin Injections Revenue Market Share by Region (2021–2032)
Figure 34. China Human Insulin Injections Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Japan Human Insulin Injections Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. South Korea Human Insulin Injections Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. India Human Insulin Injections Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Australia Human Insulin Injections Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. China Taiwan Human Insulin Injections Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Southeast Asia Human Insulin Injections Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Latin America Human Insulin Injections Sales Market Share by Country (2021–2032)
Figure 42. Latin America Human Insulin Injections Revenue Market Share by Country (2021–2032)
Figure 43. Mexico Human Insulin Injections Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Brazil Human Insulin Injections Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Argentina Human Insulin Injections Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Colombia Human Insulin Injections Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Middle East and Africa Human Insulin Injections Sales Market Share by Country (2021–2032)
Figure 48. Middle East and Africa Human Insulin Injections Revenue Market Share by Country (2021–2032)
Figure 49. Turkey Human Insulin Injections Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Saudi Arabia Human Insulin Injections Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. UAE Human Insulin Injections Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Global Sales Market Share of Human Insulin Injections by Type (2021–2032)
Figure 53. Global Revenue Market Share of Human Insulin Injections by Type (2021–2032)
Figure 54. Global Human Insulin Injections Price (US$/Dose) by Type (2021–2032)
Figure 55. Global Sales Market Share of Human Insulin Injections by Application (2021–2032)
Figure 56. Global Revenue Market Share of Human Insulin Injections by Application (2021–2032)
Figure 57. Global Human Insulin Injections Price (US$/Dose) by Application (2021–2032)
Figure 58. Human Insulin Injections Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Smart Grid Digital Substation Market Research Report 2026
Mar 17, 26
Global Photovoltaic Molded Case Circuit Breaker Market Research Report 2026
Mar 17, 26
Global Roll-Roll Automobile Business Market Research Report 2026
Mar 17, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232